Elizabeth Krawczynska

Prognostic Value of Thallium-201 Single-Photon Emission Computed Tomography for Patients With Multivessel Coronary Artery Disease After Revascularization (The Emory Angioplasty Versus Surgery Trial (EAST))

The aim of this study was to investigate the relation between reversible thallium single-photon emission computed tomography (SPECT) myocardial perfusion defects at 1-year after revascularization and quantitative indexes in Emory Angioplasty versus Surgery Trial (EAST) and outcomes 3 years after revascularization in 336 patients. EAST was a randomized controlled trial assessing cardiac outcomes for angioplasty versus bypass surgery for patients with multivessel coronary artery disease. During this prospective trial, a substudy included the evaluation of the prognostic value of reversible defects on quantitative thallium SPECT. At 1-year after revascularization, 336 patients underwent SPECT thallium-201 stress myocardial perfusion and 3-hour delayed imaging. Subsequent events, percutaneous transluminal coronary angioplasty, coronary artery bypass graft surgery, myocardial infarction, and death, were recorded at 3 years. A stress-induced reversible thallium-201 defect was defined using a quantitative index of a reversibility score >30% and severity score >500. Reversible defects were observed more frequently in the percutaneous transluminal coronary angioplasty than in the coronary artery bypass graft surgery treatment groups (46% vs 27%, p <0.001). A total of 123 patients had stress-induced, reversible thallium defects and more events than patients with other perfusion results (freedom from all events was 81.3% vs 94% [p <0.001], and freedom from myocardial infarction and death 88.3% vs 95.5% [p = 0.031]). Quantitative thallium SPECT at 1 year after revascularization risk stratifies patients as to their likelihood of major cardiac outcomes.

Clinical validation of three-dimensional color-modulated displays of myocardial perfusion

BackgroundTwo-dimensional polar maps have been validated previously with coronary arteriography for determining vascular involvement of defects from a patient’s myocardial perfusion distributions with and without quantification. The purpose of this study was to validate previously developed three-dimensional color-modulated surface displays representing myocardial perfusion.Methods and ResultsThe validation consisted of comparing the agreement between the three-dimensional displays and two-dimensional polar maps in localizing perfusion defects to vascular territories in 30 patients (16 men/14 women) who underwent both a 1-day rest/stress exercise 99mTc-labeled sestamibi study and coronary arteriography. Reading by two experts was used to identify the size and location of quantified defects and corresponding areas of reversibility seen in the polar maps and, on a separate day, in the three-dimensional displays. Agreement between the two-dimensional polar maps and the three-dimensional displays resulted in identical percentages for the localization of both defects and reversibilities: left anterior descending coronary artery, 87% (26/30); left circumflex coronary artery, 97% (29/30); right coronary artery, 97% (29/30); and coronary artery disease, 97% (29/30).ConclusionsThese results show that the color-modulated three-dimensional displays are at least as good as the CEqual polar maps in localizing a perfusion defect and its reversibility to angiographically defined vascular territories and thus could be used in the routine clinical evaluation of myocardial perfusion.

Prognosis in Patients With Left Ventricular Apical Aneurysm Diagnosed by Thallium-201 or Tc-99m Sestamibi SPECT Images

The prognosis of patients with left ventricular (LV) aneurysm diagnosed by thallium single-photon emission computed tomography (Tl-SPECT) or technetium-99m sestamibi SPECT (MIBI) has not previously been defined. Of 9,505 Tl or MIBI patients, 139 with apical infarct and probable LV aneurysm on tomographic images were identified. Patients were grouped by the presence of divergent versus parallel LV walls. Divergent walls show increasing separation of the walls as they approach the apex on vertical or horizontal long-axis slices. The degree of the deformation at the apex (divergent vs parallel walls), extent of impaired myocardium (total number of pixels in the defect/total number of pixels in the myocardium x 100%), percentage of reversibility, and segmental and total severity of standard deviations of perfusion defects were calculated. Seventy-six patients underwent contrast ventriculography. Patients with divergent walls (n = 57) were older (p = 0.05), had lower ejection fractions (p = 0.012), higher lung uptake (only Tl patients (p = 0.06), and more frequent ST elevation on the resting electrocardiogram (p = 0.009) than patients with nondivergent (parallel) walls. For both groups, the percent impaired myocardium was comparably high (44 +/- 9% vs 46 +/- 10%). Analysis of asynergic segments in 76 patients who underwent contrast ventriculography showed more akinetic, paradoxical, or aneurysmal segments in the apical region of the left ventricle in the group with SPECT divergent walls. Cox model analysis showed divergence as the significant correlate of death. At 5 years, survival for the group with divergent walls was 52% compared with 75% for those with nondivergent walls (p = 0.008). Despite significant apical LV impairment in both groups, mortality was almost twice as high in the group with divergent walls compared with patients with parallel walls. Thus, patients with LV aneurysm diagnosed by radionuclide SPECT perfusion imaging have a higher mortality when displaying a divergent wall pattern than patients with lesser deformity.